, Tracking Stock Market Picks
Enter Symbol:
Celldex Therapeutics, Inc. (CLDX) [hlAlert]

up 197.44 %

Celldex Therapeutics, Inc. (CLDX) rated Buy with price target $24 by Cantor Fitzgerald

Posted on: Monday,  Jul 8, 2013  8:25 AM ET by Cantor Fitzgerald

Cantor Fitzgerald rated Buy Celldex Therapeutics, Inc. (NASDAQ: CLDX) on 07/08/2013. Previously Cantor Fitzgerald rated Buy Celldex Therapeutics, Inc. (NASDAQ: CLDX) on
04/04/2012., when the stock price was $5.08. Since then, Celldex Therapeutics, Inc. has gained 197.44% as of 01/25/2016's recent price of $15.11.
If you would have followed the previous Cantor Fitzgerald's recommendation on CLDX, you would have gained 197.44% of your investment in 1391 days.

Celldex Therapeutics, Inc. (Celldex) is a biopharmaceutical company, which applies its Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. The Company?s immunotherapy platform includes a portfolio of monoclonal antibodies, antibody-targeted vaccines, antibody-drug conjugates and immunomodulators to create disease-specific drug candidates. Its collaborations include the commercialization of an oral human rotavirus vaccine and the development of oncology and infectious disease vaccines. On October 1, 2009, Celldex acquired CuraGen Corporation.

Cantor U.S. Equity Research provides timely and insightful opinions on select stocks. We look at key drivers of the stock price, including company and industry fundamentals, capital markets influences and overall economic trends to provide critical and in-depth analysis. Our focus is on small and mid-cap companies in the following sectors: * Marine Transportation * Life Sciences * Clean Technology & Energy Efficiency * Real Estate * Communications Technology * Internet * Enterprise Software
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/8/2013 8:25 AM Buy
21.65 24.00
as of 12/13/2013
1 Week down  -12.94 %
1 Month down  -12.03 %
3 Months down  -5.77 %
1 YTD up  235.61 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/8/2013 8:25 AM Buy
11.79 16.00
1/10/2013 8:25 AM Buy
7.59 13.00
9/14/2012 8:25 AM Buy
5.96 9.00
4/4/2012 8:25 AM Buy
5.08 7.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy